Induction and postremission therapy: new agents.
Stone
R M
RM
Adult Leukemia Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016503:Drug Delivery Systems; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D012074:Remission Induction / Q000379:methods
D000970:Antineoplastic Agents